乙氢去甲奎宁

Optochin (or ethylhydrocupreine hydrochloride) is a derivative of hydroquinine introduced in 1911 by Morgenroth and Levy with the intention to treat pneumococci infection. In very high dilutions inhibits the growth of representatives of all four groups of pneumococci in vitro. That is the main reason it is now used in cell culture techniques for the presumptive identification of Streptococcus pneumoniae, which is optochin-sensitive, from other alpha-hemolytic streptococci such as viridans streptococci, which are resistant. A common mnemonic is \"OVRPS\" (Optochin - Viridans [are] Resistant, Pneumoniae [are] Sensitive). Or \"VROPS\" (Viridans Resistant [to] Optochin, Pneumoniae Sensitive); The growth of bacteria that are optochin-sensitive will be inhibited around an optochin disc, while the growth of bacteria that are optochin-resistant will not be affected. In vitro, a solution of as little as 1:10,000,000 may be inhibitory to the pneumococcus, and 1:500,000 is bactericidal.